Recently, CD11b+ tumor-infiltrating myeloid cells (TIMs) were shown to interact with other immune cells, especially CD163+ tumor-associated macrophages (TAMs) and CD8+ tumor-infiltrating lymphocytes (TILs), in the tumor microenvironment [20,21]. This evidence concerns the gene CD8A and neoplasm.